Indication
Pontocerebellar Hypoplasia Type 6 (PCH6)
1 clinical trial
1 product
Product
VatiquinoneClinical trial
Efficacy and Safety Study of Vatiquinone for the Treatment of Mitochondrial Disease Subjects With Refractory EpilepsyStatus: Completed, Estimated PCD: 2023-03-18